Advertisement

Virchows Archiv

, Volume 461, Issue 6, pp 639–646 | Cite as

The presence of sinusoidal CD163+ macrophages in lymph nodes is associated with favorable nodal status in patients with breast cancer

  • Aaron S. MansfieldEmail author
  • Paivi Heikkila
  • Karl von Smitten
  • Jukka Vakkila
  • Marjut Leidenius
Original Article

Abstract

As macrophages are some of the first cells to encounter metastatic tumor cells in sentinel lymph nodes (SLN) and natural killer (NK) cells are critical to the cytotoxicity of abnormal cells, we sought to determine if these cell populations were altered in the presence of nodal metastasis. We used immunohistochemistry to assess the SLN of 47 patients with breast cancer (36 with nodal metastasis and 11 without nodal metastasis) and 10 control lymph nodes. We assessed metastatic areas and nonmetastatic areas separately for CD163, a marker of macrophages, and ANK-1, a marker for precursors of activated NK cells. Positively stained cells were manually counted in multiple high-power fields and averaged. Groups were compared with the Kruskal–Wallis test. Spearman rank order test was used for correlations. There was a lower frequency of CD163+ macrophages in the SLN of patients with breast cancer (median, 11.0 %; range, 4.1–20.4 %) than controls (median, 16.5 %; range, 8.9–19.6 %; p = 0.002). There were no differences in the expression of ANK between patients with cancer (median, 1.4 %; range, 0.23–6.3 %) and controls (median, 1.5 %; range, 0.60–5.4 %; p = 0.5). In patients with nodal metastasis, the accumulation of CD163+ cells in the sinuses correlated negatively with CD8+ tumor-infiltrating lymphocytes (r 2 = 0.23; p = 0.001). These results suggest that the reduction of CD163+ macrophages in the sinuses of the SLN is associated with nodal metastasis and may have a role in regional immunity.

Keywords

Breast cancer Macrophages Natural killer cells Lymph nodes 

Notes

Conflict of interest

We declare that we have no conflict of interest.

References

  1. 1.
    Mansfield AS, Heikkila PS, Vaara AT, von Smitten KA, Vakkila JM, Leidenius MH (2009) Simultaneous Foxp3 and IDO expression is associated with sentinel lymph node metastases in breast cancer. BMC Cancer 9:231PubMedCrossRefGoogle Scholar
  2. 2.
    Mansfield AS, Heikkila P, von Smitten K, Vakkila J, Leidenius M (2011) Metastasis to sentinel lymph nodes in breast cancer is associated with maturation arrest of dendritic cells and poor co-localization of dendritic cells and CD8(+) T cells. Virchows Arch 459:391–398PubMedCrossRefGoogle Scholar
  3. 3.
    Matsuura K, Yamaguchi Y, Osaki A, Ohara M, Okita R, Emi A, Murakami S, Arihiro K (2009) FOXP3 expression of micrometastasis-positive sentinel nodes in breast cancer patients. Oncol Rep 22:1181–1187PubMedCrossRefGoogle Scholar
  4. 4.
    Matsuura K, Yamaguchi Y, Ueno H, Osaki A, Arihiro K, Toge T (2006) Maturation of dendritic cells and T-cell responses in sentinel lymph nodes from patients with breast carcinoma. Cancer 106:1227–1236PubMedCrossRefGoogle Scholar
  5. 5.
    Kohrt HE, Nouri N, Nowels K, Johnson D, Holmes S, Lee PP (2005) Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer. PLoS Med 2:e284PubMedCrossRefGoogle Scholar
  6. 6.
    Angel CE, Chen CJ, Horlacher OC, Winkler S, John T, Browning J, MacGregor D, Cebon J, Dunbar PR (2009) Distinctive localization of antigen-presenting cells in human lymph nodes. Blood 113:1257–1267PubMedCrossRefGoogle Scholar
  7. 7.
    Chambers AF, Groom AC, MacDonald IC (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2:563–572PubMedCrossRefGoogle Scholar
  8. 8.
    Nathanson SD (2003) Insights into the mechanisms of lymph node metastasis. Cancer 98:413–423PubMedCrossRefGoogle Scholar
  9. 9.
    Lanier LL (2008) Evolutionary struggles between NK cells and viruses. Nat Rev Immunol 8:259–268PubMedCrossRefGoogle Scholar
  10. 10.
    Sun JC, Beilke JN, Lanier LL (2009) Adaptive immune features of natural killer cells. Nature 457:557–561PubMedCrossRefGoogle Scholar
  11. 11.
    Li S, Xu J, Makarenkova VP, Tjandrawan T, Vakkila J, Reichert T, Gooding W, Lagenaur CF, Achim CL, Chambers WH, Herberman RB, Whiteside TL, Vujanovic NL (2004) A novel epitope of N-CAM defines precursors of human adherent NK cells. J Leukoc Biol 76:1187–1199PubMedCrossRefGoogle Scholar
  12. 12.
    Mansour EG, Ravdin PM, Dressler L (1994) Prognostic factors in early breast carcinoma. Cancer 74:381–400PubMedCrossRefGoogle Scholar
  13. 13.
    Nemoto T, Vana J, Bedwani RN, Baker HW, McGregor FH, Murphy GP (1980) Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer 45:2917–2924PubMedCrossRefGoogle Scholar
  14. 14.
    Rosen PP, Groshen S, Saigo PE, Kinne DW, Hellman S (1989) Pathological prognostic factors in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma: a study of 644 patients with median follow-up of 18 years. J Clin Oncol 7:1239–1251PubMedGoogle Scholar
  15. 15.
    Leidenius MH, Krogerus LA, Toivonen TS, von Smitten KA (2005) Sentinel node biopsy is not sensible in breast cancer patients with large primary tumours. Eur J Surg Oncol 31:364–368PubMedCrossRefGoogle Scholar
  16. 16.
    Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, Law SK, Moestrup SK (2001) Identification of the haemoglobin scavenger receptor. Nature 409:198–201PubMedCrossRefGoogle Scholar
  17. 17.
    Martens JH, Kzhyshkowska J, Falkowski-Hansen M, Schledzewski K, Gratchev A, Mansmann U, Schmuttermaier C, Dippel E, Koenen W, Riedel F, Sankala M, Tryggvason K, Kobzik L, Moldenhauer G, Arnold B, Goerdt S (2006) Differential expression of a gene signature for scavenger/lectin receptors by endothelial cells and macrophages in human lymph node sinuses, the primary sites of regional metastasis. J Pathol 208:574–589PubMedCrossRefGoogle Scholar
  18. 18.
    Leidenius MH, Vironen JH, Heikkila PS, Joensuu H (2010) Influence of isolated tumor cells in sentinel nodes on outcome in small, node-negative (pT1N0M0) breast cancer. Ann Surg Oncol 17:254–262PubMedCrossRefGoogle Scholar
  19. 19.
    Leidenius MH, Krogerus LA, Toivonen TS, Von Smitten KJ (2003) The feasibility of intraoperative diagnosis of sentinel lymph node metastases in breast cancer. J Surg Oncol 84:68–73PubMedCrossRefGoogle Scholar
  20. 20.
    Leikola JP, Toivonen TS, Krogerus LA, von Smitten KA, Leidenius MH (2005) Rapid immunohistochemistry enhances the intraoperative diagnosis of sentinel lymph node metastases in invasive lobular breast carcinoma. Cancer 104:14–19PubMedCrossRefGoogle Scholar
  21. 21.
    Sica A, Schioppa T, Mantovani A, Allavena P (2006) Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 42:717–727PubMedCrossRefGoogle Scholar
  22. 22.
    Gordon S (2003) Alternative activation of macrophages. Nat Rev Immunol 3:23–35PubMedCrossRefGoogle Scholar
  23. 23.
    Mantovani A, Marchesi F, Porta C, Sica A, Allavena P (2007) Inflammation and cancer: breast cancer as a prototype. Breast 16(Suppl 2):S27–S33PubMedCrossRefGoogle Scholar
  24. 24.
    Tsutsui S, Yasuda K, Suzuki K, Tahara K, Higashi H, Era S (2005) Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density. Oncol Rep 14:425–431PubMedGoogle Scholar
  25. 25.
    Gooden MJ, de Bock GH, Leffers N, Daemen T, Nijman HW (2011) The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis. Br J Cancer 105:93–103PubMedCrossRefGoogle Scholar
  26. 26.
    Mihm MC Jr, Clemente CG, Cascinelli N (1996) Tumor infiltrating lymphocytes in lymph node melanoma metastases: a histopathologic prognostic indicator and an expression of local immune response. Lab Invest 74:43–47PubMedGoogle Scholar
  27. 27.
    Dewan MZ, Takada M, Terunuma H, Deng X, Ahmed S, Yamamoto N, Toi M (2009) Natural killer activity of peripheral-blood mononuclear cells in breast cancer patients. Biomed Pharmacother 63:703–706PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  • Aaron S. Mansfield
    • 1
    Email author
  • Paivi Heikkila
    • 2
  • Karl von Smitten
    • 3
  • Jukka Vakkila
    • 4
  • Marjut Leidenius
    • 3
  1. 1.Medical OncologyMayo ClinicRochesterUSA
  2. 2.Department of PathologyHelsinki University Central HospitalHelsinkiFinland
  3. 3.Breast Surgery UnitHelsinki University Central HospitalHelsinkiFinland
  4. 4.Hematology Research UnitHelsinki University Central HospitalHelsinkiFinland

Personalised recommendations